Solid Biosciences Inc.
SLDB· Nasdaq
Released May 14, 2021, before the open
10-Q filed May 14, 2021, 44 days after period end · 0001564590-21-027807
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$16.90M | -$26.69M | -$29.58M | -$15.88M |
| EPS Diluted |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
| -$0.19 |
| -$0.56 |
| -$0.85 |
| -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.